New York 2025 Session Status: Passed Senate

S8925 — Prohibits the sale of 7-hydroxymitragynine products

Last action — Passed Assembly

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed Assembly
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the Senate. Introduced January 16, 2026. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the Assembly.

Prognosis

Stalled 26% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Passed Senate

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

The bill bans the sale of products containing high levels of 7-hydroxymitragynine.

This legislation prohibits the sale of products with over 2% 7-hydroxymitragynine or more than one milligram per serving. It also sets fines for violations.

Summary

Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.

Bill Text

Action History

  1. RETURNED TO SENATE

  2. PASSED ASSEMBLY

  3. ORDERED TO THIRD READING RULES CAL.408

  4. SUBSTITUTED FOR A9156B

  5. REFERRED TO WAYS AND MEANS

  6. DELIVERED TO ASSEMBLY

  7. PASSED SENATE

  8. ADVANCED TO THIRD READING

  9. 2ND REPORT CAL.

  10. 1ST REPORT CAL.1297

  11. PRINT NUMBER 8925A

  12. AMEND AND RECOMMIT TO CONSUMER PROTECTION

  13. REFERRED TO CONSUMER PROTECTION

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S8925 do?
Prohibits the sale of products that contain 7-hydroxymitragynine at a level that exceeds 2% of total alkaloids or one milligram per serving; establishes fines for the sale of such products.
Who sponsors S8925?
S8925 is sponsored by Christopher Ryan.
What is the current status of S8925?
This bill has passed the Senate. Introduced January 16, 2026. It now moves to the second chamber.
Where can I track S8925?
Track S8925 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S8925

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S8925

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →